Clinical Trials for Varicella (Chickenpox)

A Study to Evaluate Immunogenicity and Safety After the First and Second Doses of MG1111 (BARYCELA Inj.) in Healthy Children Aged 12 Months to 12 Years

NCT ID: NCT07054099

This clinical trial is studying a new chickenpox vaccine called MG1111 (BARYCELA Inj.) to see if it works as well and is as safe as the current vaccine called VARIVAX. The study will include health...